glp-1 parkinson's disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular and neurodegenerative disorders Incretin and insulin signaling as

12 , e70027 (2024)

My daughter was diagnosed with B12 deficiency last year and her B12 test results said her level was so low it was unable to be read

One of the most common questions people have about peptide therapy is whether its safe

The first few weeks are primarily the body adapting to the appetite-regulating effects of the medication

Haque et al found Cd-toxicity triggers plant growth retardation, chlorosis, low photosynthesis performance, and low Fe, S, and Zn concentrations in sugar beets, which were related to decline FCR activity and BvIRT1 gene expression, suggesting the negative effect of Cd-toxicity on Fe acquisition process in sugar beet [7]